Stifel Trust’s Novartis NVS Stock Holding History

Stifel Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4.78M	Sell	56,621 -642	-1%	-$51.9K	0.91%	43
2014 Q2	$4.65M	Sell	57,263 -971	-2%	-$76.4K	0.87%	49
2014 Q1	$4.44M	Sell	58,234 -1,254	-2%	-$91.4K	0.84%	51
2013 Q4	$4.29M	Sell	59,488 -3,625	-6%	-$252K	0.8%	50
2013 Q3	$4.34M	Sell	63,113 -145	-0.2%	-$9.59K	0.86%	47
2013 Q2	$4.01M	Buy	+63,258	New	+$4.12M	0.83%	50

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stifel Trust's NVS Position: Q3 2014 in Review

Stifel Trust reduced its Novartis (NVS) stake by 1.1% in Q3 2014, selling an estimated $51.9K and leaving 56,621 shares worth $4.78M. The position accounts for 0.91% of the portfolio, ranked #43.

Stifel Trust first reported a position in NVS in Q2 2013 and has held it in 6 quarters since. 874 funds tracked by Wall St. Rank hold NVS as of Q3 2014.

Stifel Trust held 56,621 shares of Novartis worth $4.78M as of Q3 2014.
Stifel Trust sold 642 Novartis shares in Q3 2014, an estimated $51.9K.
Novartis made up 0.91% of Stifel Trust's portfolio in Q3 2014, its #43 holding.
Stifel Trust first reported a position in Novartis in Q2 2013 and has held it in 6 quarters since.
874 funds tracked by Wall St. Rank held Novartis as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.